14701871

Source:http://linkedlifedata.com/resource/pubmed/id/14701871

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006826, umls-concept:C0087111, umls-concept:C0805586, umls-concept:C1171350, umls-concept:C1527148
pubmed:issue	24
pubmed:dateCreated	2003-12-31
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8711660
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0890-9369
pubmed:author	pubmed-author:SawyersCharles LCL
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2998-3010
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:14701871-Animals, pubmed-meshheading:14701871-Antineoplastic Agents, pubmed-meshheading:14701871-Clinical Trials as Topic, pubmed-meshheading:14701871-Drug Design, pubmed-meshheading:14701871-Enzyme Inhibitors, pubmed-meshheading:14701871-Humans, pubmed-meshheading:14701871-Neoplasms, pubmed-meshheading:14701871-Protein-Tyrosine Kinases
pubmed:year	2003
pubmed:articleTitle	Opportunities and challenges in the development of kinase inhibitor therapy for cancer.
pubmed:affiliation	Howard Hughes Medical Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. csawyers@mednet.ucla.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Review, Research Support, Non-U.S. Gov't